NOVEL TARGETS FOR THERAPIES OF HCV INFECTIONS

The present invention relates to eight newly identified human proteins that specifically interact with hepatitis C virus protein NS5A, and their use as novel targets for treatment of infections and diseases caused by Hepatitis C. L'invention concerne huit protéines humaines nouvellement identif...

Full description

Saved in:
Bibliographic Details
Main Authors GAO, JUNJUN, LANGEN, HANNO, GRUENBAUM, LORE, SANKABATHULA, SAILAJA, AUGUSTIN, ANGELIQUE, NAJERA, ISABEL, LAMERZ, JENS, MEISTERMANN, HELENE, KLUMPP, KLAUS, TZOUROS, MANUEL, LE POGAM, SOPHIE, GOLLING, SABRINA
Format Patent
LanguageEnglish
French
Published 20.03.2014
Subjects
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to eight newly identified human proteins that specifically interact with hepatitis C virus protein NS5A, and their use as novel targets for treatment of infections and diseases caused by Hepatitis C. L'invention concerne huit protéines humaines nouvellement identifiées qui interagissent spécifiquement avec la protéine NS5A du virus de l'hépatite C, et leur utilisation en tant que nouvelles cibles pour traiter les infections et les maladies induites par l'hépatite C.
Bibliography:Application Number: WO2013EP68583